Concepedia

Marie-Charlotte Hallouin-Bernard

MH

Statistics

Publications

3

Citations

223

H-Index

3

Active since

2019

Affiliations

Inserm(Current)

Assistance Publique – Hôpitaux de Paris

Marie-Charlotte Hallouin-Bernard is an author at Inserm specializing in vaccine safety, immunology, and vaccinology.

Top concepts

Publications per year

2019–2022

3

Publications

3

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 164 citations · Full text

, , +8

Rapid characterization of a Delta-Omicron SARS-CoV-2 recombinant detected in Europe

Etienne Simon‐Lorière, Xavier Montagutelli, Frédéric Lemoine et al. · 2022 · 33 citations · Full text

Weekly Sequential Antibioprophylaxis for Recurrent Urinary Tract Infections Among Patients With Neurogenic Bladder: A Randomized Controlled Trial

Aurélien Dinh, Marie-Charlotte Hallouin-Bernard, Benjamin Davido et al. · Clinical Infectious Diseases · 2019 · 26 citations

1–3 of 3